Holen Sie sich die Stockscreener-App
8.93
3.98%
-0.37
Handel nachbörslich:
8.60
-0.33
-3.70%
Schlusskurs vom Vortag:
$9.30
Offen:
$9.17
24-Stunden-Volumen:
848.81K
Relative Volume:
0.72
Marktkapitalisierung:
$242.49M
Einnahmen:
$157.75M
Nettoeinkommen (Verlust:
$-29.73M
KGV:
-7.6983
EPS:
-1.16
Netto-Cashflow:
$-21.00M
1W Leistung:
-9.62%
1M Leistung:
-60.42%
6M Leistung:
-30.40%
1J Leistung:
-49.89%
1-Tages-Spanne:
$8.835
$9.40
1-Wochen-Bereich:
$8.835
$10.12
52-Wochen-Spanne:
$8.04
$24.17
Arcturus Therapeutics Holdings Inc Stock (ARCT) Company Profile
Firmenname
Arcturus Therapeutics Holdings Inc
Sektor
Branche
Telefon
(858) 900-2660
Adresse
10628 SCIENCE CENTER DRIVE, SAN DIEGO, CA
Vergleichen Sie ARCT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ARCT
Arcturus Therapeutics Holdings Inc
|
8.93 | 252.54M | 157.75M | -29.73M | -21.00M | -1.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -906.14M | -6.1812 |
Arcturus Therapeutics Holdings Inc Stock (ARCT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-24 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2025-10-23 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-10-22 | Herabstufung | Guggenheim | Buy → Neutral |
| 2025-09-04 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-05-28 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-01-28 | Eingeleitet | BTIG Research | Buy |
| 2024-08-12 | Eingeleitet | Leerink Partners | Outperform |
| 2023-12-13 | Eingeleitet | Canaccord Genuity | Buy |
| 2023-07-24 | Eingeleitet | William Blair | Outperform |
| 2023-05-11 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2022-11-14 | Fortgesetzt | Wells Fargo | Overweight |
| 2022-11-10 | Herabstufung | Robert W. Baird | Neutral → Underperform |
| 2022-11-03 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-11-02 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2022-08-10 | Herabstufung | Raymond James | Mkt Perform → Underperform |
| 2022-07-19 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2022-05-11 | Hochstufung | Robert W. Baird | Underperform → Neutral |
| 2022-04-21 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-01-31 | Hochstufung | Raymond James | Underperform → Mkt Perform |
| 2021-08-12 | Herabstufung | Raymond James | Mkt Perform → Underperform |
| 2021-08-11 | Herabstufung | Goldman | Neutral → Sell |
| 2021-08-10 | Herabstufung | Robert W. Baird | Neutral → Underperform |
| 2021-07-02 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-06-25 | Fortgesetzt | Goldman | Neutral |
| 2021-06-21 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2021-06-04 | Fortgesetzt | Robert W. Baird | Neutral |
| 2021-02-17 | Herabstufung | B. Riley Securities | Neutral → Sell |
| 2021-01-19 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2021-01-15 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2021-01-07 | Eingeleitet | Wells Fargo | Overweight |
| 2020-12-29 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2020-12-29 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2020-12-29 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2020-12-29 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-12-23 | Herabstufung | ROTH Capital | Buy → Sell |
| 2020-12-08 | Bestätigt | B. Riley Securities | Buy |
| 2020-12-07 | Bestätigt | B. Riley Securities | Buy |
| 2020-10-26 | Eingeleitet | Barclays | Overweight |
| 2020-10-06 | Eingeleitet | Citigroup | Buy |
| 2020-08-26 | Eingeleitet | Piper Sandler | Overweight |
| 2020-07-30 | Fortgesetzt | ROTH Capital | Buy |
| 2020-07-16 | Eingeleitet | Raymond James | Outperform |
| 2020-07-13 | Eingeleitet | B. Riley FBR | Buy |
| 2020-06-09 | Herabstufung | WBB Securities | Buy → Hold |
| 2020-02-11 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-02-07 | Eingeleitet | Guggenheim | Buy |
| 2020-02-06 | Eingeleitet | Guggenheim | Buy |
| 2019-04-05 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-09-20 | Hochstufung | WBB Securities | Buy → Strong Buy |
| 2018-01-22 | Eingeleitet | Chardan Capital Markets | Buy |
Alle ansehen
Arcturus Therapeutics Holdings Inc Aktie (ARCT) Neueste Nachrichten
Ongoing Securities Investigation into Arcturus Therapeutics Holdings Inc. (ARCT)Contact Levi & Korsinsky - ACCESS Newswire
Arcturus Therapeutics (NASDAQ: ARCT) at Guggenheim Nov. 12 & Jefferies Nov. 17–20 - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Is Investigating Arcturus Therapeutics Holdings Inc. (ARCT) And Encourages Shareholders to Connect - ACCESS Newswire
Is Arcturus Therapeutics Holdings Inc. stock ready for a breakoutMarket Sentiment Review & Verified Momentum Watchlists - newser.com
Arcturus Therapeutics (ARCT) to Release Earnings on Monday - MarketBeat
How Arcturus Therapeutics Holdings Inc. stock valuations compare to rivalsJuly 2025 Macro Moves & Real-Time Buy Zone Alerts - newser.com
How to use a screener to detect Arcturus Therapeutics Holdings Inc. breakoutsWeekly Trend Summary & Community Consensus Stock Picks - newser.com
Real time scanner hits for Arcturus Therapeutics Holdings Inc. explainedJuly 2025 News Drivers & Risk Adjusted Swing Trade Ideas - newser.com
What MACD signals say about Arcturus Therapeutics Holdings Inc.M&A Rumor & Pattern Based Trade Signal System - newser.com
Can momentum traders help lift Arcturus Therapeutics Holdings Inc.Weekly Profit Report & Free Real-Time Volume Trigger Notifications - newser.com
Ongoing Investigation Into Arcturus Therapeutics Holdings Inc. (ARCT): Contact Levi & Korsinsky About Potential Fraud - ACCESS Newswire
Protect Your Investment: Contact Levi & Korsinsky About the Arcturus Therapeutics Holdings Inc. (ARCT) Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Arcturus Therapeutics Holdings Inc. (ARCT) And Encourages Investors to Connect - ACCESS Newswire
Earnings Preview: Arcturus Therapeutics (ARCT) Q3 Earnings Expected to Decline - Yahoo Finance
Arcturus Therapeutics Holdings Inc. stock volume spike explainedTrade Exit Summary & Stepwise Trade Signal Implementation - newser.com
Is Arcturus Therapeutics Holdings Inc. stock cheap at current valuationJuly 2025 Action & Fast Momentum Stock Entry Tips - newser.com
Published on: 2025-11-03 05:43:35 - newser.com
Can Arcturus Therapeutics Holdings Inc. stock beat market expectations this quarterEarnings Recap Report & Fast Gaining Stock Reports - newser.com
Advanced analytics toolkit walkthrough for Arcturus Therapeutics Holdings Inc.2025 Top Gainers & Community Verified Swing Trade Signals - newser.com
What candlestick patterns are forming on Arcturus Therapeutics Holdings Inc.Market Growth Summary & Free Weekly Chart Analysis and Trade Guides - newser.com
Published on: 2025-11-02 01:11:00 - newser.com
How Arcturus Therapeutics Holdings Inc. stock compares to market leadersVolume Spike & Advanced Technical Signal Analysis - newser.com
How to forecast Arcturus Therapeutics Holdings Inc. trends using time seriesQuarterly Growth Report & Accurate Intraday Trading Signals - newser.com
Published on: 2025-11-01 04:30:36 - newser.com
Is Arcturus Therapeutics Holdings Inc. stock attractive for income investorsJuly 2025 Selloffs & Safe Entry Momentum Tips - newser.com
Sumitomo Mitsui Trust Group, Inc. Expands Stake in Arcturus Ther - GuruFocus
Potential Securities Fraud: Levi & Korsinsky Investigates Arcturus Therapeutics Holdings Inc. (ARCT) - ACCESS Newswire
High Growth Tech Stocks In US With Promising Potential - simplywall.st
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Arcturus Therapeutics Holdings Inc. (ARCT) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
2025-10-31 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Arcturus Therapeutics Holdings Inc. (ARCT) and Encourages Investors to Learn More About the Investigation | NDAQ:ARCT | Press Release - Stockhouse
How currency fluctuations impact Arcturus Therapeutics Holdings Inc. stockPortfolio Update Report & Proven Capital Preservation Methods - newser.com
What technical models suggest about Arcturus Therapeutics Holdings Inc.’s comebackJuly 2025 EndofMonth & Weekly Momentum Stock Picks - newser.com
Arcturus Therapeutics Holdings (ARCT) Price Target Decreased by 30.87% to 45.67 - MSN
Arcturus Therapeutics Holdings Inc. (ARCT) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Arcturus Therapeutics Holdings Inc. (ARCT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Published on: 2025-10-30 03:05:20 - newser.com
Arcturus Therapeutics Holdings Inc. $ARCT Shares Sold by Sumitomo Mitsui Trust Group Inc. - MarketBeat
Finanzdaten der Arcturus Therapeutics Holdings Inc-Aktie (ARCT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.45%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):